NYSE: HQL - Tekla Life Sciences Investors

छह महीने के लिए लाभप्रदता: -14.59%
भाग प्रतिफल: +12.12%
सेक्टर: Financials

पदोन्नति कार्यक्रम Tekla Life Sciences Investors


कंपनी के बारे में Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

अधिक जानकारी
It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

IPO date 1992-05-04
ISIN US87911K1007
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 15.06
Дивиденд ао 2.33
Сайт https://www.teklacap.com/hql.html
Цена ао 13.01
प्रति दिन मूल्य परिवर्तन: -0.7704% (12.98)
प्रति सप्ताह मूल्य परिवर्तन: -1.98% (13.14)
प्रति माह मूल्य परिवर्तन: -4.1% (13.43)
3 महीने में कीमत में बदलाव: -4.59% (13.5)
छह महीने में कीमत में बदलाव: -14.59% (15.08)
प्रति वर्ष मूल्य परिवर्तन: -5.5% (13.63)
3 वर्षों में मूल्य परिवर्तन: -21.03% (16.31)
5 वर्षों में मूल्य परिवर्तन: -22.97% (16.72)
वर्ष की शुरुआत से मूल्य परिवर्तन: -1.83% (13.12)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 4.88 3
P/BV 0.9204 9
P/E 4.96 10
EV/EBITDA 14.85 7
कुल: 8.63

क्षमता

नाम अर्थ श्रेणी
ROA, % 19.76 6
ROE, % 19.8 6
कुल: 5.17

लाभांश

नाम अर्थ श्रेणी
Div yield, % 12.12 10
DSI 0.8571 8.57
कुल: 7.58

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -30.15 0
लाभप्रदता Ebitda, % -131.71 0
लाभप्रदता EPS, % -41.09 0
कुल: 0

लाभांश, % लाभांश अवधि के परिणामों के आधार पर पहले खरीदें रजिस्ट्री बंद होने की तारीख पहले भुगतान करें
3.49% 0.469 IV кв. 2024 19.02.2025 21.02.2025 10.03.2025
3.85% 0.5 III кв. 2024 19.11.2024 21.11.2024 06.12.2024

संस्थानों आयतन शेयर करना, %
Saba Capital Management, L.P. 1421300 5.42
Cornerstone Advisors, LLC 494340 1.89
1607 Capital Partners, LLC 480179 1.83
Allspring Global Investments Holdings, LLC 454154 1.73
Morgan Stanley 430266 1.64
AQR Arbitrage LLC 384231 1.47
Clough Capital Partners, LP 375410 1.43
RPO LLC 338542 1.29
Needham Investment Management, L.L.C. 313792 1.2
Flagship Harbor Advisors, LLC 264003 1.01

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
Saba Closed End Funds ETF 2.8917 17.31 2.29022
Amplify High Income ETF 2.263 6.94 2.77149
First Trust Income Opportunities ETF 0.4681 18.3 2.48805



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. Daniel R. Omstead M.S, Ph.D. Principal Executive Officer, President and Trustee N/A 1953 (72 वर्ष)
Mr. Peter Branner Chief Investment Officer N/A 1964 (61 वर्ष)

पता: United States, Boston. MA, 100 Federal Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.teklacap.com/hql.html